Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia-Reference-Cited by-同舟云学术

Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia

Published:2023-07 Issue: Volume:93 Page:104667
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Mabrey F. Linzee^ORCID,Nian Hui,Yu Chang,Barnes Elizabeth M.,Malhotra Uma,Mikacenic Carmen,Goldstein Julia,O'Mahony D. Shane,Garcia-Diaz Julia,Finn Patricia,Voelker Kirk,Morrell Eric D.,Self Wesley H.^ORCID,Becker Patrice M.^ORCID,Martin Thomas R.,Wurfel Mark M.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference47 articles.

1. Dexamethasone in hospitalized patients with Covid-19;Horby;N Engl J Med,2021

2. Interleukin-6 receptor antagonists in critically ill patients with Covid-19;Gordon;N Engl J Med,2021

3. Baricitinib plus remdesivir for hospitalized adults with Covid-19;Kalil;N Engl J Med,2021

4. Anti-granulocyte-macrophage colony-stimulating factor monoclonal antibody gimsilumab for COVID-19 pneumonia: a randomized, double-blind, placebo-controlled trial;Criner;Am J Respir Crit Care Med,2022

5. Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, China;Tan;Immunology,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiological Study in Antiviral Innate Immunity;Methods in Molecular Biology;2024-08-28

2. Antibody drugs targeting SARS-CoV-2: Time for a rethink?;Biomedicine & Pharmacotherapy;2024-07

3. CD14 Blockade Does Not Improve Outcomes of Deep Vein Thrombosis Following Inferior Vena Cava Stenosis in Mice;2024-01-12

4. Spontaneous resolution of acute gout: mechanisms and therapeutic targets;RMD Open;2023-09